Keywords: Hyperpolarized MR (Non-Gas), Deuterium
Motivation: Deuterium metabolic imaging (DMI) is well-suited for studying glucose metabolism in multiple sclerosis (MS), which could potentially be used for disease diagnosis and monitoring.
Goal(s): To assess the ability of DMI to detect alterations in glucose metabolism in vivo in a MS mouse model.
Approach: C57BL/6J mice received regular chow (n=9) or 0.2% cuprizone (CPZ) diet for 4 weeks (n=11) followed by DMI, T2-weighted MRI, immunofluorescence and glutamate assays.
Results: Glutamate/glutamine (Glx) concentrations were increased in CPZ compared to control mice. Ex vivo analysis confirmed the increase in glutamate in CPZ mice and showed decreased myelination and increased inflammation.
Impact: DMI can assess Glx levels non-invasively in MS and could serve as a novel marker of neuronal damage following demyelination. DMI is clinically translatable and holds potential for future MS clinical trials and other disorders presenting Glx imbalance.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords